Pfizer's vaccine trial has finished with a 95% success rate. The end of the trial now means the company can push for an emergency u.s.
Media Randy Adams Blog
Randy Adams The Visionary Innovator Shaping The Future Schrum Entrepreneurship
Dalbo
